By Veronika Kyrylenko
America’s top health regulators are set to consider authorizing the use of experimental Pfizer and Moderna injections in children and infants as young as six months. The FDA’s Vaccines and Related Biological Products Advisory Committee will hold a hearing on the matter on June 14-15, and public comments are accepted until June 13. In the light of scientific evidence of the risks associated with the vaccines, many observers believe it is critically important to inundate the FDA with the letters opposing the authorization.
According to the agenda of the two-day virtual meeting, two topics will be discussed by the VRBPAC.
On June 14, the committee will discuss amending the Emergency Use Authorization (EUA) of the Moderna shot to include the administration of the primary series to children and adolescents six years through 17 years of age.
On June 15, the advisors will deliberate on amending the EUA of the Moderna shot to include the administration of the primary series to infants and children six months through five years of age. On the same day, the FDA experts will discuss expanding the EUA of the Pfizer-BioNTech shot to include infants and children six months through four years of age.
As reported by The New American, Pfizer, following the request of the FDA, submitted paperwork to the agency requesting EUA for its two-shot regimen for children between six months and five years old.
Since the two shots appear to offer little protection to that age cohort, the FDA said it needed to wait for data on third doses to see if they would generate a more robust immune response. Earlier, Pfizer admitted that while a two-dose regimen was effective in children ages six months to two years, two shots failed to promote a desired immune response in children ages two through four years.
On May 23, Pfizer announced that the mid-trial data showed that the three-dose regimen containing 3 µg each appeared to have an 80.3-percent efficacy based on symptomatic infections counted in a subset of a trial involving 1,678 children. On the following week, the company submitted the paperwork to the FDA.
Pfizer’s competitor, Moderna Inc., submitted a request to authorize its Covid shots for the same age group in April. Vaccine efficacy was reported to be just 51 percent for children six months to less than two years of age and 37 percent for children two years to less than six years of age. Those dreadful numbers did not seem to bother the FDA’s chief vaccine advisor, Dr. Peter Marks, who told the House Select Subcommittee on the Coronavirus Crisis that “the agency would not withhold authorization of a pediatric vaccine if it fails to meet the agency’s 50% efficacy threshold for blocking symptomatic infections.”
“Zero Benefits, Infinite Risks“
According to CDC data — for what’s it worth — as of June 2, infants younger than one accounted for 299, and children aged one to four for 143, out of 1,005,236 total deaths associated with Covid in the United States. Not a single child has died since March 5.
“People are being distracted with a lot of the information, but they need to focus on one thing,” said independent journalist James Roguski in an exclusive statement to The New American on Thursday. “Children don’t die from Covid. If the purpose of the vaccine is to save lives, then they have zero benefits to children while posing infinite risks.”
“No statistical or medical argument can support the recommendation for infants and young children to get experimental injections,” he added.
In his Substack post on the matter, Roguski cited multiple studies published in peer-reviewed journals supporting the claim.
17,000 medical doctors and scientists of the Global Covid summit agree: children are not at risk of severe Covid, let alone death, and should be excluded from Covid vaccinations.
What evidence that the benefits of being injected outweigh the risks does Pfizer and Moderna have? According to Roguski, the FDA will post the relevant documents on Friday, June 10.
The FDA posted public comments received after June 7 and by June 13, they will be taken into consideration by the FDA.
Roguski compiled helpful links for Americans to let the FDA know that they oppose vaccination of young children against Covid because of the following reasons:
- There is an ample proof that the Covid gene “vaccines” are deadly to children and associated with 20-100x increase in death;
- The products in question are not traditional vaccines but rather gene therapies;
- The federal government arguably withholds the data on the clinical and post-marketing safety data of the “vaccines.” In particular, the FDA argued it needed 75 years to release the Pfizer data;
- The phase 4 study for Pfizer shows “death” is the #7 outcome after 30 days;
- According to documents on the NIH website and a peer-reviewed study, the product interferes with the human genome and immune system.
The letter concludes,
The unequivocal rules of science are incorporated in the legal system which requires certain studies, and approving these products for children with no benefit and all risk would be in violation of the international and U.S. legal system. This is because required scientific studies are missing, which is also in violation of international ethics norms such as Nuremberg Code and Rome Statute Article 7 crimes against humanity if you were to approve this investigational product for babies and toddlers 6 months to 5 years.
“I view it as a turning point where people can get unified against the Big Pharma and the corrupt government. They are literally coming for our babies,” warned Roguski.
The livestream of the VRBAC meeting starts on Wednesday, June 15, at 8:30 a.m. EDT, and will be available here.